Scientists use bacterial strains found in sharks to develop a probiotic prototype that can help shrimp fight bacterial infections and so, minimise aquaculture pandemics. Researchers have announced...
Researchers from Monash University have constructed novel antimicrobial surfaces with remarkable ability to reduce bacterial growth on medical tools, potentially reducing risks of...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and...
In a study involving mice and human autopsy tissue, researchers at the National Institutes of Health and Cambridge University have shown that some of these immune cells are trained to fight...
The SARS-CoV-2 surrogate virus neutralisation test (sVNT) was the fruit of collaborative efforts among Duke-NUS Medical School, NCID, A*STAR IMCB and GenScript Biotech. Its high specificity and...
International study led by Duke-NUS scientists finds that transfluthrin-treated fabric effectively repels Anopheles mosquitoes that transmit malaria. Among disease types transmitted by mosquitoes,...
Global technology company, Orion Health announced its solution to manage the COVID-19 pandemic through its patient management platform. Since the beginning of the COVID-19 outbreak Orion Health has...
Dubbed the “Jekyll and Hyde” properties, scientists at Trinity College Dublin identified a rare, new cell in the immune system that is able to express two forms of T cells. The immune system...
Researchers at SMART, MIT’s research enterprise in Singapore and the Nanyang Technological University (NTU) discovers breakthrough that may take a step towards solving the antimicrobial resistance...
Using cryo-electron microscopy, structural features of feline infectious peritonitis virus (FIPV) can provide valuable information to understand the pathogenesis of infection. To better understand...
Clinical trial findings provide new insights to differential responses to flaviviral infections. A team of researchers from the SingHealth Duke-NUS Academic Medicine Centre’s Viral Research and...
Epclusa is the first approved single tablet regimen to treat all six major genotypes of hepatitis C virus. Gilead Sciences announced that Epclusa (sofosbuvir 400mg/velpatasvir 100mg), a once daily...
